Supplements

Post-COVID paediatric dysautonomia arises from complex brain-heart-vascular network dysfunction, with tachycardia as a compensatory response rather than primary cardiac abnormality

The paper argues that post-COVID dysautonomia in children is primarily a disorder of central autonomic network dysfunction and neurovascular dysregulation, not a primary cardiac condition. Tachycardia is described as a compensatory physiological response to impaired venous return, endothelial injury, hypovolemia, and altered cerebral perfusion.

Last updated: Jul 7, 2026โ€ข0 RCTsโ€ข๐Ÿ“– Read as article โ†’

Evidence Score

Evidence Score32/100
Human RCTโ˜†โ˜†โ˜†โ˜†โ˜†
Meta-analysisโ˜†โ˜†โ˜†โ˜†โ˜†
Mechanismโ˜…โ˜…โ˜…โ˜…โ˜…
Safetyโ˜…โ˜…โ˜…โ˜…โ˜†
Confidencelow

Study Evidence

Study 1. Post-COVID paediatric dysautonomia: never the heart, always the brain-myth or maxim?

observational

Das B, Moodley M ยท Cardiology in the young (2026)

Participants: N/A
Duration: N/A
Intervention: N/A (review/opinion piece)
Outcome: Conceptualisation of dysautonomia as a brain-heart-vascular network disorder
Effect Size: N/A
Population: Children and adolescents with post-COVID dysautonomia

Result:

Mechanism Graph

Central autonomic network dysfunction
โ†“
Neurovascular dysregulation and impaired venous return
โ†“
Endothelial injury and hypovolemia
โ†“
Altered cerebral perfusion
โ†“
Compensatory tachycardia as physiological response

Limitations

  • โš Reported prevalence varies widely due to evolving definitions and heterogeneous referral patterns
  • โš Important gaps remain in disease definitions, mechanistic understanding, and evidence-based treatment

Frequently Asked Questions

Is post-COVID dysautonomia primarily a heart problem in children?โ–ผ

No, the paper argues it is primarily a brain-heart-vascular network disorder, with tachycardia being a compensatory response rather than a primary cardiac abnormality.

What are the common symptoms of paediatric post-COVID dysautonomia?โ–ผ

Common symptoms include dizziness, palpitations, exercise intolerance, fatigue, syncope, cognitive dysfunction, gastrointestinal symptoms, sleep disturbances, and post-exertional symptom exacerbation.

How is paediatric dysautonomia managed?โ–ผ

Management follows a stepwise, mechanism-guided approach including patient education, trigger avoidance, hydration and salt optimisation, lower-body compression, individualised exercise rehabilitation, pacing strategies, school accommodations, and phenotype-directed pharmacotherapy.

What clinical phenotypes are associated with post-COVID dysautonomia?โ–ผ

Clinical phenotypes include postural orthostatic tachycardia syndrome, neurocardiogenic syncope, orthostatic hypotension, inappropriate sinus tachycardia, and undifferentiated orthostatic intolerance.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Das B, Moodley M. "Post-COVID paediatric dysautonomia: never the heart, always the brain-myth or maxim?." Cardiology in the young, 2026. PMID: 42403377 DOI: 10.1017/S1047951126113900
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.